DeepDock: Enhancing Ligand-protein Interaction Prediction by a Combination of Ligand and Structure Information
暂无分享,去创建一个
Xiaodi Huang | Tao Huang | Ronghui You | Zhirui Liao | Shanfeng Zhu | Xiaojun Yao | Xiaodi Huang | Shanfeng Zhu | Tao-wei Huang | Xiaojun Yao | R. You | Zhirui Liao
[1] Dan Li,et al. ADMET Evaluation in Drug Discovery. 16. Predicting hERG Blockers by Combining Multiple Pharmacophores and Machine Learning Approaches. , 2016, Molecular pharmaceutics.
[2] Antonio Lavecchia,et al. Machine-learning approaches in drug discovery: methods and applications. , 2015, Drug discovery today.
[3] Gang Fu,et al. PubChem Substance and Compound databases , 2015, Nucleic Acids Res..
[4] Jakub M. Tomczak,et al. Interaction prediction in structure-based virtual screening using deep learning , 2018, Comput. Biol. Medicine.
[5] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[6] Guigang Zhang,et al. Deep Learning , 2016, Int. J. Semantic Comput..
[7] Matthew D. Zeiler. ADADELTA: An Adaptive Learning Rate Method , 2012, ArXiv.
[8] Gianni De Fabritiis,et al. PlayMolecule BindScope: large scale CNN-based virtual screening on the web , 2018, Bioinform..
[9] Gary B. Fogel,et al. Computational Intelligence Methods for Docking Scores , 2009 .
[10] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[11] Hongyi Zhou,et al. FINDSITEcomb2.0: A New Approach for Virtual Ligand Screening of Proteins and Virtual Target Screening of Biomolecules , 2018, J. Chem. Inf. Model..
[12] Sebastian G. Rohrer,et al. Maximum Unbiased Validation (MUV) Data Sets for Virtual Screening Based on PubChem Bioactivity Data , 2009, J. Chem. Inf. Model..
[13] Izhar Wallach,et al. AtomNet: A Deep Convolutional Neural Network for Bioactivity Prediction in Structure-based Drug Discovery , 2015, ArXiv.
[14] David Ryan Koes,et al. Lessons Learned in Empirical Scoring with smina from the CSAR 2011 Benchmarking Exercise , 2013, J. Chem. Inf. Model..
[15] Thomas Fox,et al. Machine learning techniques for in silico modeling of drug metabolism. , 2006, Current topics in medicinal chemistry.
[16] Brian K. Shoichet,et al. Virtual screening of chemical libraries , 2004, Nature.
[17] Cícero Nogueira dos Santos,et al. Boosting Docking-Based Virtual Screening with Deep Learning , 2016, J. Chem. Inf. Model..
[18] Hao Ding,et al. Similarity-based machine learning methods for predicting drug-target interactions: a brief review , 2014, Briefings Bioinform..
[19] David Rogers,et al. Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..
[20] George Papadatos,et al. The ChEMBL database in 2017 , 2016, Nucleic Acids Res..
[21] Alán Aspuru-Guzik,et al. Convolutional Networks on Graphs for Learning Molecular Fingerprints , 2015, NIPS.
[22] David S. Wishart,et al. DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..
[23] Hao Ding,et al. Collaborative matrix factorization with multiple similarities for predicting drug-target interactions , 2013, KDD.
[24] Yoshua Bengio,et al. Deep Learning of Representations for Unsupervised and Transfer Learning , 2011, ICML Unsupervised and Transfer Learning.
[25] Ignacio Ponzoni,et al. Multi‐Objective Feature Selection in QSAR Using a Machine Learning Approach , 2009 .
[26] David Ryan Koes,et al. Protein-Ligand Scoring with Convolutional Neural Networks , 2016, Journal of chemical information and modeling.
[27] Michael M. Mysinger,et al. Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking , 2012, Journal of medicinal chemistry.